Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bandy appointment ties in with abiliti launch

This article was originally published in Clinica

Executive Summary

Weight loss therapy specialist IntraPace has appointed Bart Bandy, a veteran in the bariartric and general surgery markets, chief commercial officer. Prior to joining the Mountain View, California firm, he was the senior vice-president at gastric band market leader Inamed/Allergan Health. He has also held senior sales, marketing and general management roles with Ethicon Endo-Surgery, Karl Storz, and USGI Medical. He joins IntraPace as the firm launches its flagship obesity treatment, the abiliti system, in Europe. The device, which is CE-marked but not yet approved in the US, is implanted on the anterior side of the stomach and electrically stimulates it so that the person feels full before the stomach is actually full. The system also automatically records when a patient eats, drinks and exercises and transmits these data wirelessly so that they can be viewed by patients and physicians.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT097206

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel